Evidence map›Paper›PMID 30108658›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2018

Gut Microbiota Play an Essential Role in the Antidiabetic Effects of Rhein.

Ruifeng Wang, Pu Zang, Junxiu Chen, Fei Wu, Zhouqin Zheng, Jian Ma, Cuihua Yang, Hong Du

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. The Mechanism of Traditional Chinese Medicine for the Treatment of Obesity.Diabetes, metabolic syndrome and obesity : targets and therapy · 2020
    Review
  12. Gut Microbiota, a Potential New Target for Chinese Herbal Medicines in Treating Diabetes Mellitus.Evidence-based complementary and alternative medicine : eCAM · 2019
    Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ruifeng WangDepartment of Endocrinology, Jinling Hospital, Nanjing, China.
Pu ZangDepartment of Endocrinology, Jinling Hospital, Nanjing, China.
Junxiu ChenMedical School of Nanjing University, Nanjing, China.
Fei WuMedical School of Nanjing University, Nanjing, China.
Zhouqin ZhengSouthern Medical University, Guangzhou, China.
Jian MaDepartment of Endocrinology, Jinling Hospital, Nanjing, China.
Cuihua YangDepartment of Endocrinology, Jinling Hospital, Nanjing, China.
Hong DuDepartment of Endocrinology, Jinling Hospital, Nanjing, China.ORCID 0000-0002-8470-988X
Nanjing General Hospital of Nanjing Military Command · CNNanjing Medical University · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is clear that the gut microbiota can affect host metabolism and alterations of the gut microbiota can link with metabolic disease. Rhein has been used in traditional Chinese medicine with putative antidiabetic effects. Here we show that oral administration of rhein for 6 weeks can significantly reduce fasting blood glucose (FBG) level (8.30 ± 4.52 mmol/l versus 18.89 ± 6.06 mmol/l,

Identifiers

PMID30108658
PMCPMC6077525
OpenAlexW2863076650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.